Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal ketamine for chronic cluster headache (proof-of-concept)
2019-001260-29Phase 2Completed
- Sponsor
- CCH Pharma Pty Ltd.
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ketamine in Cluster Headache (CH), sponsored by CCH Pharma Pty Ltd. Primary endpoint: Primary: pain reduction at 15 minutes. Started Jun 2019; status: completed.
02
Drugs
ketamine
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on 2019-001260-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001260-29.